Invention Grant
- Patent Title: Methods for treatment of metastatic thyroid cancer using a PDGFR-α inhibitor
-
Application No.: US15872434Application Date: 2018-01-16
-
Publication No.: US10534000B2Publication Date: 2020-01-14
- Inventor: Todd McMullen , Raymond Lai
- Applicant: The Governors of the University of Alberta
- Applicant Address: CA Edmonton
- Assignee: The Governors of the University of Alberta
- Current Assignee: The Governors of the University of Alberta
- Current Assignee Address: CA Edmonton
- Agency: Clark & Elbing LLP
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574 ; A61P35/00 ; C07K16/28 ; C07H21/04 ; A61K31/4439 ; A61K45/06 ; A61K31/00 ; A61K31/404 ; A61K31/444 ; A61K31/713 ; A61B17/32 ; A61N5/10 ; C12N15/113
Abstract:
Provided herein are methods for identifying a subject with an increased likelihood of developing or having metastatic papillary thyroid cancer (PTC), or a subject with an increased likelihood of developing or having recurrent PTC, and the treatment of such a subject.
Public/Granted literature
- US20180164318A1 METHODS, KITS, AND SYSTEMS FOR TREATMENT OF METASTATIC PAPILLARY THYROID CANCER Public/Granted day:2018-06-14
Information query
IPC分类:
